beta-Pinene

DB15574InvestigationalSmall molecule

beta-Pinene is a mono-terpene indicated in combination with other plant-derived compounds for the treatment of bladder, kidney, and urinary stones. An ingredient from plants used to treat stones in the body.

Mechanism: Pharmacologically active on Amyloid-beta precursor protein and 5-hydroxytryptamine receptor 3
Curator reviewed
Formula / weight: C₁₀H₁₆ · 136.238 g/mol (avg)
Also known as: 2(10)-pinene · nopinene · pseudopinene · β-pinene
Code names: FEMA No. 2903

Resolves to

Compound

UNII4MS8VHZ1HJCAS127-91-3ChEMBLCHEMBL501351ChEBI50025KEGGC09882

Clinical / RWD

RxNorm1923811

Structure

InChIKeyWTARULDDTDQWMU-UHFFFAOYSA-NSMILESCC1(C)C2CC1C(=C)CC2

Targets

P05067APP

What you can answer from here — as of August 27, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Structured indicationsCondition, population, route and combination as fields, not prose

3Marketed productsAcross 2 countries and 2 labellers

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with beta-Pinene, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In